Using Novalung to Treat Respiratory and Cardiac Failure with Dr. David Thompson
A year ago, the FDA cleared a product for use in the U.S. called Novalung®, an extracorporeal membrane oxygenation system (ECMO). Listen as Dr. David Thompson, Vice President and Medical Director of Critical Care for the Renal Therapies Group, a division of Fresenius Medical Care North America, joins Field Notes to discuss successful experiences with the first ECMO system-FDA cleared for long-term use over six hours in patients with acute respiratory or acute cardiopulmonary failure.
